Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38.5M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-18.3M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$7.33M
-
Number of sells
-
-28
Significant Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q2 2025
28 filings reported holding BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q2 2025.
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 38.5M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (0 shares), SBI Securities Co., Ltd. (0 shares), Pfizer Inc (0 shares), VANGUARD GROUP INC (0 shares), JPMORGAN CHASE & CO (0 shares), XTX Topco Ltd (0 shares), BlackRock, Inc. (0 shares), NORTHERN TRUST CORP (0 shares), StoneX Group Inc. (0 shares), and Board of Trustees of The Leland Stanford Junior University (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.